Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
56
datasets available to search
ShareScore release 0.9.0
Dataset results
56 results for “Pathologic complete response”
Deep Learning Model Predicts Pathological Complete Response of Lung Cancer Following Neoadjuvant Immunochemotherapy
ClinicalTrials.gov study NCT06285058. IPD Sharing: UNDECIDED. Countries: 0. Publications: 1.
Multi-center retrospective evaluation of a RNA expression classifier to predict pathological complete response to neoadjuvant chemotherapy in breast cancer biopsies
GEO Series GSE163882. Homo sapiens. 222 samples. Type: Expression profiling by high throughput sequencing.
A specific miRNA signature correlates with complete pathological response to neoadjuvant chemo-radiotherapy in locally advanced rectal cancer
GEO Series GSE29298. Homo sapiens. 38 samples. Type: Non-coding RNA profiling by array.
MRI Split Scar Sign as a Predictor to Complete Pathologic Response After Neoadjuvant Chemoradiation in Rectal Cancer
ClinicalTrials.gov study NCT04745091. IPD Sharing: UNDECIDED. Countries: 0. Publications: 0.
Analysis of Deoxyribonucleic Acid and Ribonucleic Acid Next-Generation Sequencing in Non-Small Cell Lung Cancer Patients Without Pathological Complete Response Following Neoadjuvant Immunotherapy
ClinicalTrials.gov study NCT07179445. IPD Sharing: NO. Countries: 1. Publications: 0.
A Clinical Study Based on FAPI-PET/CT Technology to Predict Pathological Complete Response After Neoadjuvant Chemoradiotherapy for MSS Rectal Cancer
ClinicalTrials.gov study NCT06608537. IPD Sharing: NO. Countries: 1. Publications: 0.
Evaluation of the Accuracy of Percutaneous Biopsy by Vacuum-assisted Biopsy (VAB) to Assess Pathological Complete Response in Patients With Clinical and Radiological Complete Response After Neoadjuvan
ClinicalTrials.gov study NCT03876951. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Deep Learning Signature for Predicting Complete Pathological Response to Neoadjuvant Chemoimmunotherapy in Non-small Cell Lung Cancer
ClinicalTrials.gov study NCT05925751. IPD Sharing: NO. Countries: 1. Publications: 0.
Pembrolizumab vs. Observation in People With Triple-negative Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Pembrolizumab
ClinicalTrials.gov study NCT05812807. IPD Sharing: UNDECIDED. Countries: 3. Publications: 0.
Trial of Adjuvant Chemotherapy in Breast Cancer Patients With Pathological Partial Response and Complete Response to Neoadjuvant Chemotherapy
ClinicalTrials.gov study NCT02879513. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Predicting Pathological Complete Response of Rectal Cancer With Magnetic Resonance(MR) Radiomics
ClinicalTrials.gov study NCT03238885. IPD Sharing: NO. Countries: 1. Publications: 0.
Toripalimab Adjuvant Therapy in Subjects With Resected Esophageal Squamous Cell Carcinoma Who Achieved Pathological Complete Response (pCR)
ClinicalTrials.gov study NCT06903871. IPD Sharing: Not stated. Countries: 1. Publications: 0.
ShortStop-HER2: 12 Months vs. 6 Months of HER2-targeted Medications for People With HER2+ Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Trastuzumab
ClinicalTrials.gov study NCT06876714. IPD Sharing: UNDECIDED. Countries: 2. Publications: 0.
Refusal of Breast Surgery in Patients With Breast Cancer With a Clinical Complete Response (cCR) After Neoadjuvant Systemic Therapy and a Confirmed Pathological Complete Response (pCR) Using Vacuum-as
ClinicalTrials.gov study NCT04293796. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Assessment of Complete Pathologic Response After Neoadjuvant Chemotherapy for Breast Cancer
ClinicalTrials.gov study NCT03981705. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Cohort of Predictive Factor of Pathologic Complete Response After Preoperative Neoadjuvant in Rectum Cancer
ClinicalTrials.gov study NCT04443985. IPD Sharing: NO. Countries: 1. Publications: 0.
Prognostic Analysis of Esophageal Cancer with Complete Pathological Response After Neoadjuvant Therapy
ClinicalTrials.gov study NCT06889402. IPD Sharing: NO. Countries: 1. Publications: 0.
The Efficacy and Safety of Adjuvant Immunotherapy After Pathological Complete Response Following Neoadjuvant Chemoimmunotherapy in Patients with Resectable NSCLC
ClinicalTrials.gov study NCT06243679. IPD Sharing: NO. Countries: 1. Publications: 0.
Local Excision Versus Total Mesorectal Excision In Pathological Complete Response (ypT0-1cN0) Mid- Or Low-Rectal Cancer After Neoadjuvant Therapy
ClinicalTrials.gov study NCT03548844. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Lifestyle, Exercise, And Nutrition (LEAN) Trial on Pathologic Complete Response in TNBC
ClinicalTrials.gov study NCT07066189. IPD Sharing: NO. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.